periurethral bulking
Recently Published Documents


TOTAL DOCUMENTS

15
(FIVE YEARS 0)

H-INDEX

5
(FIVE YEARS 0)

2020 ◽  
Vol 26 (2) ◽  
pp. 71-78
Author(s):  
Fiona Bach ◽  
Philip Toozs-Hobson

Objective To use British Society of Urogynaecology surgical database to evaluate periurethral bulking agents and retropubic tapes. Study design Permission was granted to analyse 1386 periurethral bulking agents and 18,763 retropubic tapes. The primary outcome measure was patient reported global impression of improvement for incontinence with secondary outcomes of change in symptoms of stress incontinence, overactive bladder and complications. Results Patients undergoing periurethral bulking agents were older than retropubic tapes (mean 59.4 vs. 52.3 years). Urodynamic stress incontinence was the commonest urodynamic diagnosis (periurethral bulking agents 67%, retropubic tapes 77%) but there was a higher proportion of complex diagnoses in the periurethral bulking agents group. 59.2% patients reported ‘very much/much better’ on patient reported global impression of improvement for incontinence for periurethral bulking agents compared to 91% for retropubic tapes; 28% patients felt their symptoms of stress incontinence were cured following periurethral bulking agents compared to 77.6% for retropubic tapes and 0.8% developed de novo overactive bladder following periurethral bulking agents compared to 4% with retropubic tapes. There was no difference in outcomes when using periurethral bulking agents as a primary or secondary procedure. There were no intraoperative complications with periurethral bulking agents and fewer post-operative complications compared to retropubic tapes (3.6%). Conclusion Patient reported success of periurethral bulking agents is lower than retropubic tapes but this is offset by minimal complications despite being an older, more complex patient group. Periurethral bulking agents do appear equally efficacious as a secondary procedure. Information derived from databases can be used during counselling to allow clinicians to demonstrate their own success and complication rates to ensure patients make an informed choice. Patient choice is paramount so all options should be included in full counselling.



2018 ◽  
Vol 24 (4) ◽  
pp. 312-314 ◽  
Author(s):  
Natalie Gaines ◽  
Priyanka Gupta ◽  
Ayad S. Khourdaji ◽  
Michael Ehlert ◽  
Keval Parikh ◽  
...  


2017 ◽  
Vol 11 (6S2) ◽  
pp. 152 ◽  
Author(s):  
Adiel Mamut ◽  
Kevin V. Carlson

Urethral bulking aims to improve urethral mucosal coaptation, and thus outlet resistance, in an effort to limit stress-induced leakage. While efforts have been made to employ bulking agents to treat stress urinary incontinence (SUI) for more than 100 years, we remain wanting for the perfect injectable. Regardless of the agent studied, efficacy is modest at best, repeat injections are the norm, and longterm followup is conspicuously lacking. This treatment, however, fills an important need in our armamentarium against SUI, serving those patients who are not candidates for more invasive interventions and those with multiple prior failed surgeries. This review offers a contemporary discussion on the role of periurethral bulking therapy in Canada, along with practical aspects of its application.



2016 ◽  
Vol 195 (4S) ◽  
Author(s):  
Natalie Gaines ◽  
Priyanka Gupta ◽  
Iyad S. Khourdaji ◽  
Keval Parikh ◽  
Kim A. Killinger ◽  
...  


2015 ◽  
Vol 26 (7) ◽  
pp. 1077-1078 ◽  
Author(s):  
Ola Malabarey ◽  
Jens-Erik Walter


2011 ◽  
Vol 22 (8) ◽  
pp. 1039-1043 ◽  
Author(s):  
Disha Kumar ◽  
Melissa R. Kaufman ◽  
Roger R. Dmochowski




Sign in / Sign up

Export Citation Format

Share Document